Activin and Inhibin

AZD0095 is a selective and orally active MCT4 inhibitor ( IC 50 : 1.3 nM). AZD0095 effectively inhibits the tumor growth in NCI-H358 xenograft in combination with Cediranib ( HY-10205 )In VitroAZD0095 (0-50 µM) inhibits cell proliferation in

AZD0095 is a selective and orally active MCT4 inhibitor ( IC 50 : 1.3 nM). AZD0095 effectively inhibits the tumor growth in NCI-H358 xenograft in combination with Cediranib ( HY-10205 )In VitroAZD0095 (0-50 µM) inhibits cell proliferation in

AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pK i values of 7.93 and 9.06 for human CB1R and CB2R , respectively. AZD1940 shows a robust analgesia actionIn VitroAZD1940 binds with high affinity to human, rat

AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pK i values of 7.93 and 9.06 for human CB1R and CB2R , respectively. AZD1940 shows a robust analgesia actionIn VitroAZD1940 binds with high affinity to human, rat

AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pK i values of 7.93 and 9.06 for human CB1R and CB2R , respectively. AZD1940 shows a robust analgesia actionIn VitroAZD1940 binds with high affinity to human, rat

AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pK i values of 7.93 and 9.06 for human CB1R and CB2R , respectively. AZD1940 shows a robust analgesia actionIn VitroAZD1940 binds with high affinity to human, rat

AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pK i values of 7.93 and 9.06 for human CB1R and CB2R , respectively. AZD1940 shows a robust analgesia actionIn VitroAZD1940 binds with high affinity to human, rat

AZD4625 (Compound 21) is a highly potent, selective, covalent and allosteric inhibitor of the mutant GTPase KRAS G12C . AZD4625 has high oral bioavailability.Appearance:SolidIC50&amp: Target:KRAS(G12C)Biological Activity:AZD4625 (Compound 21) is a

AZD5904 is a selective and irreversible inhibitor of human Myeloperoxidase ( MPO ) with an IC 50 of 140 nM and has similar potency in mouse and rat.In VitroAZD5904 is a pselective and irreversible inhibitor of human Myeloperoxidase (MPO) with an IC

AZD8154 is a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.Form:SolidIC50&amp: Target:PI3Kγ.

AZD8154 is a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.Form:SolidIC50&amp: Target:PI3Kγ.

AZD8154 is a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.IC50&amp: Target:PI3Kγ.